首页> 外文会议>World biomaterials congress >Gene expression and canonical pathways in experimental frozen-thawed ovarian grafts treated with scaffold-base delivery of adipose tissue-derived stem cells
【24h】

Gene expression and canonical pathways in experimental frozen-thawed ovarian grafts treated with scaffold-base delivery of adipose tissue-derived stem cells

机译:支架组织输送脂肪组织干细胞对冷冻冻融的卵巢移植物的基因表达和经典途径的影响

获取原文

摘要

Introduction: Previous works of our group demonstrated that cellular therapy with adipose tissue-derived stem cells (ASC) in a scaffold-based delivery is better than the directly injection for improve the quality of frozen-thawed ovarian autografts. However, new researchers are necessary to evaluate the gene profile expressed in this graft to ensure that this therapy. Materials and Methods: Twelve 12-week-old adult female Wistar rats were use. Frozen-thawed ovarian grafts of adult female rats were treated with rat ASC delivery in an acellular matrix (Gelfoam) immediately after an autologous retroperitoneal transplant (n=6). Controls received Gelfoam with vehicle (DMEM low glucose, n=6). The ovarian grafts were retrieved 30 days after transplantation. Quantitative gene expression (qPCR) for apoptosis, angiogenesis and inflammatory cytokines (84 genes in each pathway) were evaluated by Real Time-Polymerase Chain Reaction (RT-PCR). All reactions were performed in triplicate and controlled by negative RT (no enzyme) and no-template controls and all gene expression levels were normalized to the mean of the internal genes. A Fold Regulation reference value of -2 and +2 was considered for expression analyses. Further analyses were done by Ingenuity Pathway Analysis (IPAO) software in order to determine the main canoninal pathways and the expression values of the top molecules. Results and Discussion: The top canonical pathways involved were Tweak Signaling (53%), Induction of Apoptosis (43%), Apoptosis Signaling (32%), Death Receptor Signaling (30%) and Hepatic fibrosis (17%). The top diseases and biofunctions envolved were: Organismal Injury and Abnormalities (121 molecules), Cancer (118), Inflammatory Response (108), Connective Tissue Disorders (76) and Tumor Morphology (75). The top tox functions were: Increased Levels of Alkaline Phosphatase (11 molecules), AST (7), ALT (6) and Creatinine (6) and Decreased Levels of Albumin (5). The 10 top molecules up-regulated, in descending order, were HPSE (+16.4 Fold Change), IL21 (+9.9), S1PR1 (+8.4), IL1A(+7.1), HGF (+7), CXCL11 (+6.7), CCL19 (+6.4), CCR3 (+6.2), CCR6 (+5.4) and LTB (+5.1). The 10 top molecules down-regulated, in descending order, were Hrk (-73.2), CASP14 (-71.1), TP73 (-34.1), DFFB (-27.8), DP63 (-26), CIDEB (-25.7), LTA (-23.6), BCL2L11 (-19.8), CD40LG (-18.5) and CIDEA (-17.8). Conclusion: ASC therapy based on scaffold base-delivery strategy in rat ovarian autografts activated canonical pathways mainly involved with apoptosis. New researchers are necessary to evaluate the real benefit of this treatment.
机译:简介:我们小组的先前工作表明,在基于支架的递送中使用脂肪组织来源的干细胞(ASC)进行细胞疗法优于直接注射,以改善冷冻融化的卵巢自体移植的质量。但是,新的研究人员有必要评估这种移植物中表达的基因谱,以确保这种疗法。材料和方法:使用十二只12周大的成年雌性Wistar大鼠。成年雌性大鼠的冻融卵巢移植物在自体腹膜后腹膜移植后立即用无细胞基质(Gelfoam)中的大鼠ASC递送进行处理(n = 6)。对照接受带有媒介物的明胶泡沫(DMEM低葡萄糖,n = 6)。移植后30天取回卵巢移植物。通过实时聚合酶链反应(RT-PCR)评估凋亡,血管生成和炎性细胞因子(每种途径中的84个基因)的定量基因表达(qPCR)。所有反应均一式三份进行,并通过阴性RT(无酶)和无模板对照进行控制,所有基因表达水平均标准化为内部基因的平均值。折叠调节参考值为-2和+2,用于表达分析。通过Ingenuity Pathway Analysis(IPAO)软件进行了进一步分析,以确定主要的标准途径和顶级分子的表达值。结果与讨论:涉及的主要规范途径是调节信号(53%),细胞凋亡诱导(43%),细胞凋亡信号(32%),死亡受体信号(30%)和肝纤维化(17%)。涉及的主要疾病和生物功能是:生物损伤和异常(121个分子),癌症(118个),炎症反应(108个),结缔组织疾病(76个)和肿瘤形态学(75个)。最高的毒物功能是:碱性磷酸酶(11个分子),AST(7),ALT(6)和肌酐(6)水平升高,白蛋白水平降低(5)。上调的10个最高分子按降序排列是HPSE(+16.4倍变化),IL21(+9.9),S1PR1(+8.4),IL1A(+7.1),HGF(+7),CXCL11(+6.7) ,CCL19(+6.4),CCR3(+6.2),CCR6(+5.4)和LTB(+5.1)。下调的10个最高分子依次为Hrk(-73.2),CASP14(-71.1),TP73(-34.1),DFFB(-27.8),DP63(-26),CIDEB(-25.7),LTA (-23.6),BCL2L11(-19.8),CD40LG(-18.5)和CIDEA(-17.8)。结论:基于支架碱基递送策略的ASC疗法在大鼠卵巢自体移植中激活了与凋亡相关的经典途径。需要新的研究人员来评估这种治疗的真正益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号